Skip to content

Retinal Artery Study in participants with obstructive sleep apnoea treated with continuous positive airway pressure

A pilot, randomised controlled trial of retinal artery flicker induced vasodilatation to detect change in endothelial function in participants with obstructive sleep apnoea treated with continuous postitive airway pressure for 6 weeks.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000311055
Enrollment
30
Registered
2010-04-19
Start date
2010-04-15
Completion date
2010-12-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Evidence has accumulated that changes to the tiny blood vessels at the back of the eye (retinal arteries) are linked to heart disease. It is possible to use a simple eye examination to view these tiny retinal blood vessels and get an idea about their condition. This kind of examination is simple to perform and is not invasive. Because there are similarities to blood vessels throughout the body, an eye examination could be used to provide important information about blood vessel condition in general and whether certain treatments can result in improved blood vessel function. This study will examine the retinal arteries of a group of patients with Obstructive Sleep Apnoea and risk factors for or actual heart disease. It will also look for evidence that the function of the retinal arteries improves with Continuous Positive Airway Pressure (CPAP) treatment

Interventions

6 weeks Continuous Positive Airway Pressure (CPAP) individually titrated and fitted for use during sleep.

Sponsors

Austin Health Department of Cardiology and Institute for Breathing and Sleep
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Moderate to severe Obstructive Sleep Apnoea(OSA) - Apnoea Hypopnoea Index greater than or equal to 30, with associated hypoxaemia – Oxygen saturation(Sa O2) <90% for a minimumm of 6% of total sleep time. Actual coronary artery disease or two or more of the following cardiovascular risk factors – hypertension, dyslipidaemia, diabetes, smoking, positive family history.

Exclusion criteria

Commercial driver or patients listed for urgent CPAP implementation. Glaucoma

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026